Indian American founded company partners University of Houston for Covid-19 vaccine

iNDICA NEWS BUREAU- The University of Houston has entered into an exclusive license agreement with an Indian American co-founded company for developing novel vaccines for respiratory diseases like COVID-19. AuraVax Therapeutics Inc., a Houston based biotech company has agreed to exclusively license a new intranasal COVID-19 vaccine technology developed by Navin Varadarajan, M.D. Anderson Professor […]

ViroVax’s adjuvant to enhance response to Bharat Biotech’s Covaxin

IANS-  Leading pharmaceutical company Bharat Biotech will use Kansas-based ViroVax’s adjuvant Alhydroxiquim-II to boost the immune response to its coronavirus vaccine Covaxin. Covaxin is an inactivated vaccine derived from a strain of SARS-CoV-2 virus, isolated at the National Institute of Virology (NIV), Pune. The inactivated virus is formulated with ViroVax’s adjuvant to produce the vaccine […]